产品详情
简单介绍：
Anti-CDKN2A/p19ARF抗体产品质量稳定，实验效果明显，货期快，价格优惠，欢迎垂询订购！我公司长期供应**组化抗体、WB抗体、**组化试剂盒和抗体试验所需全部相关试剂、荧光标记抗体、单克隆抗体、多克隆抗体、各种标记的二抗IgG/IgM/IgD/IgA等科研实验抗体。Anti-CDKN2A/p19ARF抗体用于**组化实验,WB实验,相应的标记抗体有HRP标记抗体,FITC标记,BIO等。
详情介绍：
Rabbit Anti-CDKN2A/p19ARF
Cat. Number:
Anti-CDKN2A/p19ARF抗体KL-0534R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
P19ARF Capable of inducing cell cycle arrest in G1 and G2 phases. Acts as a tumor suppressor. Binds to MDM2 and blocks its nucleocytoplasmic shuttling by sequestering it in the nucleolus. This inhibits the oncogenic
Anti-CDKN2A/p19ARF抗体action of MDM2 by blocking MDM2-induced degradation of p53 and enhancing p53-dependent transactivation and apoptosis. Also induces G2 arrest and apoptosis in a p53-independent manner by preventing the activation of cyclin B1/CDC2 complexes. Binds to BCL6 and down-regulates BCL6-induced transcriptional repression. Binds to E2F1 and MYC and blocks their transcriptional activator activity but has no effect on MYC transcriptional repression. Binds to TOP1/TOPOI and stimulates its activity. This complex binds to rRNA gene promoters and may play a role in rRNA transcription and/or maturation. Interacts with NPM1/B23 and promotes its polyubiquitination and degradation, thus inhibiting rRNA processing. Interacts with UBE2I/UBC9 and enhances sumoylation of a number of its binding partners including MDM2 and E2F1. Binds to HUWE1 and represses its ubiquitin ligase activity. May play a role in controlling cell proliferation and apoptosis during mammary gland development.
Also known as:
MTS1; ARF; CDK4 inhibitor
Anti-CDKN2A/p19ARF抗体P16 INK4; CDKN2A; Cyclin dependent kinase inhibitor 2A; INK4; P19; P19ARF; p19INK4a.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, .
●
Immunogen: KLH conjugated synthetic peptide derived from human P19ARF.
●
Predicted Molecular Weight:
Anti-CDKN2A/p19ARF抗体19kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions Anti-CDKN2A/p19ARF抗体must be determined by the end user.
Not yet tested in other applications.
Optimal working dilutions Anti-CDKN2A/p19ARF抗体must be determined by the end user.
kl885Hu01 血清淀粉样蛋白A(SAA)多克隆抗体 Polyclonal Antibody to Serum Amyloid A (SAA)
kl885Mu01 血清淀粉样蛋白A(SAA)多克隆抗体 Polyclonal Antibody to Serum Amyloid A (SAA)
kl885Rb52 血清淀粉样蛋白A(SAA)多克隆抗体 Polyclonal Antibody to Serum Amyloid A (SAA)
kl886Bo01 过氧化物酶体增殖物激活受体γ(Pklγ)多克隆抗体 Polyclonal Antibody to Peroxisome Proliferator Activated Receptor Gamma (Pklg)
kl886Hu01 过氧化物酶体增殖物激活受体γ(Pklγ)多克隆抗体 Polyclonal Antibody to Peroxisome Proliferator Activated Receptor Gamma (Pklg)
kl886Mu01 过氧化物酶体增殖物激活受体γ(Pklγ)多克隆抗体 Polyclonal Antibody to Peroxisome Proliferator Activated Receptor Gamma (Pklg)
kl886Ra01 过氧化物酶体增殖物激活受体γ(Pklγ)多克隆抗体 Polyclonal Antibody to Peroxisome Proliferator Activated Receptor Gamma (Pklg)
kl887Hu01 丙酮酸脱氢酶磷酸酶(PDP)多克隆抗体 Polyclonal Antibody to Pyruvate Dehydrogenase Phosphatase (PDP)
kl887Mu01 丙酮酸脱氢酶磷酸酶(PDP)多克隆抗体 Polyclonal Antibody to Pyruvate Dehydrogenase Phosphatase (PDP)
kl888Hu01 补体成分4(C4)多克隆抗体 Polyclonal Antibody to Complement Component 4 (C4)
kl888Mu01 补体成分4(C4)多克隆抗体 Polyclonal Antibody to Complement Component 4 (C4)
kl888Ra01 补体成分4(C4)多克隆抗体 Polyclonal Antibody to Complement Component 4 (C4)
kl889Ca01 肾素(REN)多克隆抗体 Polyclonal Antibody to Renin (REN)
